mayo clinic glp-1 Study identifies patients with obesity most likely to benefit from GLP-1-based treatment GLP-1 medications: Mayo Clinic expert

It can be easier for brands that deal with a lot of different types of ingredients to organise their work when producers are vertically integrated

Morgan Stanley estimated in 2024 that employer GLP-1 coverage generates USD 8,200 in annual healthcare cost savings per successfully treated employee with obesity generating positive ROI within 3 to 5 years

Another study indicates that inhibition of MCT3 impairs the transport of lactate out of skeletal muscle, potentially promoting SMCs proliferation and facilitating the development of atherosclerosis

Additionally, tree-based ML algorithms such as XGBoost, LightGBM, and AdaBoost have been used to classify T2D patients based on metabolite data, achieving high accuracy and sensitivity in distinguishing T2D from non-diabetic controls (161)